Recombinant Human FGF23 Protein，His

Fibroblast growth factor 23 (FGF23) is a key regulatory protein involved in phosphate metabolism and vitamin D homeostasis. It is primarily produced by osteocytes and osteoblasts in response to increased phosphate levels and is crucial for maintaining phosphate balance by promoting renal excretion of phosphate and inhibiting the synthesis of 1,25-dihydroxyvitamin D. Abnormal levels of FGF23 are associated with various metabolic disorders, including chronic kidney disease, where it contributes to dysregulated phosphate and calcium homeostasis. Researchers have focused on recombinant FGF23 for its potential therapeutic applications, particularly in conditions characterized by elevated phosphate levels, such as X-linked hypophosphatemia and tumor-induced osteomalacia. The production and characterization of recombinant FGF23 enables a deeper understanding of its biological functions and interactions within signaling pathways, facilitating the development of FGF23-based therapies. Moreover, studying FGF23 in a recombinant form provides insights into its structure-function relationships and may pave the way for novel treatments targeting phosphate-related disorders. Overall, the investigation of recombinant FGF23 holds promise in advancing our understanding of mineral metabolism and devising innovative therapeutic strategies for diseases associated with phosphate imbalance.